Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Bristol-Myers Squibb resubmits UFT NDA to FDA

April 26, 2000

Proapoptotic and antiproliferative chroman-based compounds designed by RDF

April 26, 2000

SafeScience's phase II trial of GBC-590 expanded

April 25, 2000

Lipophilic platinum complex superior to cisplatin in rat hepatic tumor model

April 25, 2000

FDA approves Camptosar as first-line treatment of metastatic colorectal cancer

April 25, 2000

Progen's angiogenesis inhibitor slows tumor growth in rats

April 25, 2000

Biovector Therapeutics initiates phase II trial of melanoma vaccine

April 24, 2000

Apoptosis-initiating gene acquired by Idun

April 24, 2000

Idec enters two agreements for prostate cancer immunotherapy

April 24, 2000

BioInvent to produce therapeutic antibody for Wilex

April 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...